← Compound index
COMPOUND RECORD / ADK-963

ADK-963АДК-963

Immune Function
Source linked
Research profile — evidence review incomplete. Topic tags are research navigation, not indications or recommendations. Source access does not establish effectiveness or safety.
01 / OVERVIEW

What is it?

An ortho-hydroxyphenyl aminoadamantane research code in the immune-regulation dissertation. Exact structure and stereochemistry require the original chemistry record.

Research context

An ortho-hydroxyphenyl aminoadamantane research code in the immune-regulation dissertation. Exact structure and stereochemistry require the original chemistry record.

What the studies found

animal · Year not established

Multiple mouse strains and laboratory immune assays

The programme reports preparation-dependent antibody-forming-cell, T-cell and post-irradiation colony responses. ADK-910 showed a strong humoral response without increasing the delayed-hypersensitivity endpoint; immune stimulation was not uniform across assays.

Limit: OCR transcription requires comparison with the original; author/date and full tables are not entered as verified metadata.

Role of neurotropic adamantane-containing compounds in the regulation of immunity ↗

Selected findings, not a systematic review or a treatment recommendation. Combination and related-preparation results cannot be attributed to this compound alone. See each source for access status and remaining limitations.

Working classification
Experimental adamantane / analogue
Research collection
Actoprotection & occupational pharmacology · editorial grouping
Institutional provenance
Not established for this compound record
Last evidence review
Full evidence review pending; source-check scope appears with each publication below.
02 / EVIDENCE DIMENSIONS

What do we know?

Human research
—No human efficacy findings verified in this update
Study methods
—Source-specific animal, chemistry, patent or dissertation evidence
Independent replication
—Independent replication not established; translations are not separate experiments
Source access
—Access and review depth appear with each linked record
Safety evidence
—Human safety and interactions not established; animal activity is not a safe-use recommendation

These are independent review fields, not a rating. Missing evidence in this starter does not mean no research exists.

Chlodantane, Cyclontane and the ADK research programme ↗

03 / SOURCE TRAIL

Linked sources

Explore the research map and unresolved leads ↗

Year unconfirmedAnimal / experimentalRussian source · see review scope

Role of neurotropic adamantane-containing compounds in the regulation of immunity

· Dissertation; OCR reproduction

Format: Dissertation abstract transcription · Reviewed: See scope

· Dissertation author’s abstract; third-party Russian transcription

The programme reports preparation-dependent antibody-forming-cell, T-cell and post-irradiation colony responses. ADK-910 showed a strong humoral response without increasing the delayed-hypersensitivity endpoint; immune stimulation was not uniform across assays.

Population / setting
Multiple mouse strains and laboratory immune assays
What was checked
Selected source passages checked; complete methods and risk of bias not appraised.
Limitations & review scope
  • OCR transcription requires comparison with the original; author/date and full tables are not entered as verified metadata.
  • Immune and colony assays do not demonstrate better health, infection prevention or long-term stem-cell expansion in people.

Source checked 2026-10-03. This is a source-linked record, not a completed evidence review.

Read the source ↗
Browse bibliography & PDFs ↗